On this page
Back to topApnimed APMD
Apnimed listed on Nasdaq on 31 Jul 2026 and is not in the S&P 500. It is worth $718 million. Its price history starts on 31 Jul 2026. 7 directors have filed with the SEC in the last 12 months (who counts), 1 of them an executive. 2 other officers are on file.
- CEO
- Kevin Robert Lind
- Listed
- 31 Jul 2026 on Nasdaq, IPO filings and terms
- Headquarters
- Cambridge, MA
- Market cap
- $718M
- 19 Nov 2026 close
- Revenue
- -
- No annual report yet
Financials
Financial history
Twelve months to 30 Sep 2026, from Apnimed's quarterly filings.
Quarters since Jun 2025
- P/E
- -
- No profit over the last four quarters
Quarterly results
Each quarter's revenue, net income and free cash flow.
Jun 2025 to Sep 2026
Not reported for enough quarters.
| Quarter | Revenue | Net income |
|---|---|---|
| Sep 2026 | $2M | $-30M |
| Jun 2026 | $12M | $126M |
| Sep 2025 | $9M | $-11M |
| Jun 2025 | $17M | $-69M |
Apnimed's market cap since July 2026
Weekly, up to 13 Nov 2026
| Week ending | Market cap |
|---|---|
| 13 Nov 2026 | $700M |
Download Apnimed's data as JSON, with the weekly market caps in billions of dollars from 31 Jul 2026.
Board and leadership
Board and officers
1 person here also holds roles at other S&P 500 companies.
Roles filed up to 30 Sep 2026
| Name | Title |
|---|---|
| Directors (7) | |
| Kevin Robert LindChief Executive Officer | |
| Chris DimitropoulosDirector | |
| Paul R. FonteyneDirector | |
| William A. Jones Jr.Director | |
| Lawrence G. MillerDirector | |
| Paul J. SekhriDirectorAlso at Veeva Systems | |
| Gary SenderDirector | |
| Officers (2) | |
| Michael B. KellyChief Financial OfficerLast filed 3 Aug 2026 | |
| Dennis Patrick MolnarPresidentLast filed 3 Aug 2026 | |
Owners and trading
Insider trades
Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.
Trades from 19 Nov 2025 to 19 Nov 2026
Directors and officers made no open-market sales and bought $200,000 in 1 purchase in the 12 months to 19 Nov 2026.
| Date | Person | Value |
|---|---|---|
| 3 Aug 2026Buy | Paul J. SekhriDirector | $200K |
Not on file: no trades disclosed by members of Congress or officials since November 2023, no WARN layoff notices under its own name or a listed subsidiary's since November 2023, no open roles from its careers site yet, no earnings release figures from the last six months and no director or officer changes, WARN notices or large insider sales in the last two years. 13F holdings: Apnimed listed after the last quarter (30 Jun 2026). The next 13F filings were due by 14 Nov 2026.